Nektar Therapeutics (NKTR) Looks Good: Stock Up 6.8% in Session

24-01-2014 Zacks.comComments (0)

BiotechnologyNektar Therapeutics

Nektar Therapeutics (NKTR - Snapshot Report) was a big mover last session, as the company saw its shares rise nearly 7% on the day. This jump can be attributable to solid volume too with far more shares changing hands than in a normal session.


Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top